News

Position Paper on the impacts of COVID-19 on European health R&I activities

Published on: 18/03/2020

Position Paper on the impacts of COVID-19 on European health R&I activities
Covid-19

Several European organisations have expressed their concern about the potential impact of the COVID-19 pandemic on the health research and innovation ongoing projects and current calls for proposals. 

In this Position Paper they stress the need for a careful assessment of such impact and the postponement of the April deadlines for the H2020 Societal Challenge 1 at least until the end of May 2020. 

This large group of organisations wishes to communicate an important message to the European institutions confirming their strong support to any decisions the EC is undoubtedly currently working on in relation to Horizon 2020 active projects and calls. 

In such a difficult moment, stepping up the response to the outbreak remains the foremost priority and we want to renovate our commitment to work together to overcome the current challenges with continued cooperation and solidarity.

More and more organisations are expressing their support. If you wish to endorse the paper please contact Valentina Tageo, valentina@echalliance.com

NEWS​

Related News

New Round Tables announced to drive progress on EHDS and health AI

3 Jul 2025

The European Accessibility Act Is Here. Are You Ready?

2 Jul 2025
Why inclusive design is no longer optional – and how Big Motive can help you lead the way.

DTH-Lab Director: The G7 must act now to address the digital health transformation

2 Jul 2025
As digital platforms increasingly shape health systems and information flows, the G7 must lead in setting global standards to ensure safety, equity an...

InnoHSupport Open Calls

1 Jul 2025
Welcome to the InnoHSupport Open Calls!

Transformative Health Instrument Call 2025

1 Jul 2025
Apply to the Transformative Health Instrument (THI) Call 2025 if you are a growing and innovative healthcare start-up working on solutions that have s...

Longitude Prize on ALS

1 Jul 2025
The £7.5 million (~$10 million) Longitude Prize on ALS incentivises the use of AI-based approaches to transform drug discovery for amyotrophic lateral...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *